Ironwood Pharmaceuticals

formerly Ironwood PharmaIPO

Leaders in GI Health Innovation

Public · Boston, United States · Founded 1998 · $175.0M raised

Employees
201–500
Founded
1998
Business Model
B2B
Total Funding
$175.0M
Last Round
$175.0M Corporate RoundFeb 2019
Rounds
1
Type
Public

About

Ironwood Pharmaceuticals is a pioneering GI-focused biopharmaceutical company dedicated to advancing treatments for gastrointestinal diseases. Best known as originator of linaclotide (marketed as LINZESS), the US market leader for IBS-C and chronic idiopathic constipation. In 2023 the FDA approved LINZESS for pediatric functional constipation. Ironwood partners with AbbVie on US commercialization.

Summary

Ironwood Pharmaceuticals is a Biotech company based in Boston, United States, founded in 1998. It has raised $175.0M in total across 1 round, most recently a $175.0M Corporate Round round in Feb 2019.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundFeb 2019
$175.0M

Sign up to see all 4 rounds

IPO through Corporate Round — per-round amounts, valuations, and who invested in each round.

Acquisitions

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ironwood Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/ironwood-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/ironwood-pharmaceuticals" alt="Ironwood Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>